Xiangmin Cui
Insider Reports History
- Location
- Shandong
- Signature
- /s/ Stephen Dang, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Xiangmin Cui:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Health Inc. | Director | Common Stock | 788,441 | $236,532 | $0.3000 | 28 Sep 2021 | Indirect |
| ALPINE IMMUNE SCIENCES, INC. | Director, 10%+ Owner | Common Stock | 0 | $0 | $6.33 | 18 May 2024 | Indirect |
| Nuvation Bio Inc. | Director | Stock Option (Right to Buy) | 74,813 | 27 Feb 2026 | Direct | ||
| ALPINE IMMUNE SCIENCES, INC. | Director, 10%+ Owner | Stock Option (Right to buy) | 0 | 20 May 2024 | Direct | ||
| ALPINE IMMUNE SCIENCES, INC. | Director, 10%+ Owner | Warrant (right to buy) | 0 | 18 Jan 2024 | Indirect | ||
| Cue Health Inc. | Director | Series C-1 Preferred Stock | 0 | 28 Sep 2021 | Indirect |